您的位置: 首页 > 农业专利 > 详情页

ANTICORPS DIRIGES CONTRE LES MUTANTS DE DELETION DU RECEPTEUR DU FACTEUR DE CROISSANCE EPIDERMIQUE ET UTILISATIONS CORRESPONDANTES
专利权人:
INC.;ABGENIX
发明人:
WEBER, RICHARD,FENG, XIAO,FOORD, ORIT,GREEN, LARRY,GUDAS, JEAN,KEYT, BRUCE,LIU, YING,RAYA, ROBERT,YANG, XIAO DONG,CORVALAN, JOSE,JIA, XIAO-CHI,KANG, JASPAL,KLAKAMP, SCOTT L.,SU, QIAOJUAN JANE,FOLTZ, I
申请号:
CA2530285
公开号:
CA2530285C
申请日:
2004.06.25
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present invention relates to novel antibodies, particularly antibodiesdirected against deletion mutants of epidermalgrowth factor receptor and particularly to the type III deletion mutant,EGFRvIII. The invention also relates to human monoclonalantibodies directed against deletion mutants of epidermal growth factorreceptor and particularly to EGFRvIII. Diagnostic andtherapeutic formulations of such antibodies, and immunoconjugates thereof, arealso provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充